DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹1,653 Cr | ₹1,261 Cr | ₹2,459 Cr | ₹1,912 Cr | ₹1,947 Cr |
What is the latest Cash Flow from Operating Activities ratio of DIVIS LABORATORIES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2025 | ₹1,653 Cr |
Mar2024 | ₹1,261 Cr |
Mar2023 | ₹2,459 Cr |
Mar2022 | ₹1,912 Cr |
Mar2021 | ₹1,947 Cr |
How is Cash Flow from Operating Activities of DIVIS LABORATORIES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2025 | ₹1,653 Cr | 31.09 | |
Mar2024 | ₹1,261 Cr | -48.72 | |
Mar2023 | ₹2,459 Cr | 28.62 | |
Mar2022 | ₹1,912 Cr | -1.80 | |
Mar2021 | ₹1,947 Cr | - |
Compare Cash Flow from Operating Activities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹176,625.2 Cr | 0.5% | -2.9% | 35.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,273.0 Cr | 2.5% | 4.1% | -0.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,316.0 Cr | 6.2% | 9.3% | 17.9% | Stock Analytics | |
CIPLA | ₹125,993.0 Cr | 4.9% | 2.9% | 1.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,795.0 Cr | 2.1% | 1.2% | -5% | Stock Analytics | |
MANKIND PHARMA | ₹106,278.0 Cr | -0.5% | 12.5% | 23.8% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 0.5% |
-2.9% |
35.7% |
SENSEX | -1.5% |
-2.5% |
0.2% |
You may also like the below Video Courses